Write a comment
A new research trial is under way at Daisy Hill Hospital in Newry aimed at improving the quality of life for adults with kidney disease by conducting overnight dialysis.
The Nightlife study is a clinical trial assessing if overnight dialysis, performed three times a week in a hospital improves the quality of life of people with kidney failure compared to those who have shorter dialysis sessions during the day. The study is also taking place at other locations across the UK.
Daisy Hill is the first hospital on the island of Ireland to take part in the trial which will take place in the Southern Health and Social Care Trust’s Renal Unit at the Hospital. Thirteen patients are already taking part with eight of them already started their overnight dialysis.
Around 90 people currently attend the Renal Unit in Daisy Hill for dialysis, which is a lifesaving treatment for those living with kidney failure. The Unit opened in 1998 with just six dialysis stations and 24 patients and over the years, it has been ranked amongst the best in the UK and Northern Ireland for patient experience and quality of care.
Judi Graham, Consultant Nephrologist, says nocturnal dialysis has reportedly given patients an overall improved sense of wellbeing, with more time available during the day to socialise, work and care for others.
“In most cases, the haemodialysis appointment we currently offer last four hours, three times per week, with additional travel time and very little flexibility. Patients’ diet and fluid intake are often very restrictive and despite the benefits of receiving treatment, patients can often suffer from symptoms such as fatigue, impacting on their quality of their life.
“Overnight dialysis is a lengthier treatment, typically lasting six to eight, leading to more waste products being removed from the blood as well as more gentle removal of excess fluid from the body. Studies suggest that overnight dialysis can potentially have lots of benefits for patients including better blood test results, improved blood pressure control, improved heart health and reduced medications."
Trudy Reid, Director of Medicine and Unscheduled Care, said “We know that taking part in studies can enhance quality of life and improve patient care. This would not be possible without the support of our staff of specialist nurses, medics, pharmacists, podiatrists, social workers, dieticians and technicians who have welcomed and embraced the challenge of delivering this clinical trial.
“I would also like to thank our patients for their willingness to take part in this exciting trial. By doing so they can contribute to the future health and wellbeing of others.
